Page last updated: 2024-08-24

topotecan and Huntington Disease

topotecan has been researched along with Huntington Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jamal, I; Jana, NR; Kumar, V; Sharma, A; Shekhar, S; Singh, BK; Vatsa, N	1

Other Studies

1 other study(ies) available for topotecan and Huntington Disease

Article	Year
Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease. Human molecular genetics, 2017, 01-15, Volume: 26, Issue:2 Topics: Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; DNA Topoisomerases, Type I; Gene Expression Regulation; Humans; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Neostriatum; Neurons; Topoisomerase I Inhibitors; Topotecan; Ubiquitin-Protein Ligases	2017

Article

Year

Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease.

Human molecular genetics, 2017, 01-15, Volume: 26, Issue:2

Topics: Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; DNA Topoisomerases, Type I; Gene Expression Regulation; Humans; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Motor Activity; Neostriatum; Neurons; Topoisomerase I Inhibitors; Topotecan; Ubiquitin-Protein Ligases

2017